Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

PubWeight™: 2.16‹?› | Rank: Top 2%

🔗 View Article (PMID 9473913)

Published in J Am Acad Child Adolesc Psychiatry on February 01, 1998

Authors

B Geller1, T B Cooper, K Sun, B Zimerman, J Frazier, M Williams, J Heath

Author Affiliations

1: Washington University School of Medicine, St. Louis, MO 63110, USA.

Articles citing this

Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry (2008) 2.45

Substance use disorders among adolescents with bipolar spectrum disorders. Bipolar Disord (2008) 1.94

Effective treatment for mental disorders in children and adolescents. Clin Child Fam Psychol Rev (1999) 1.90

Treating adolescents for substance abuse and comorbid psychiatric disorders. Sci Pract Perspect (2003) 1.66

Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect (2005) 1.29

Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. J Child Adolesc Psychopharmacol (2009) 1.23

Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav (2011) 1.22

Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study. Drug Alcohol Depend (2008) 1.17

The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy (2007) 1.03

Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev (2014) 1.03

Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula. BMC Psychiatry (2010) 0.95

A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. J Clin Psychiatry (2008) 0.93

Undiagnosed Bipolar Disorder: New Syndromes and New Treatments. Prim Care Companion J Clin Psychiatry (2004) 0.92

Comorbidity in pediatric bipolar disorder. Child Adolesc Psychiatr Clin N Am (2009) 0.89

Psychopharmacology of pediatric bipolar disorder: a review. Psychopharmacology (Berl) (2006) 0.88

Omega-3 Supplementation for Psychotic Mania and Comorbid Anxiety in Children. J Child Adolesc Psychopharmacol (2015) 0.86

Current state of treatment for alcohol and other drug use disorders in adolescents. Alcohol Res Health (2009) 0.85

Pediatric bipolar disease: current and future perspectives for study of its long-term course and treatment. Bipolar Disord (2006) 0.83

Reasons for substance use among adolescents with bipolar disorder. Am J Addict (2010) 0.82

Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar-II disorder? Eur Arch Psychiatry Clin Neurosci (2006) 0.82

The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 2: Review, grading of the evidence and a precise algorithm. Int J Neuropsychopharmacol (2016) 0.82

Predictors of first-onset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents. J Am Acad Child Adolesc Psychiatry (2013) 0.81

Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. Bipolar Disord (2010) 0.81

Structural invariance of General Behavior Inventory (GBI) scores in Black and White young adults. Psychol Assess (2014) 0.80

Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine. BMC Psychiatry (2009) 0.80

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients. Neuropsychiatr Dis Treat (2010) 0.80

Pharmacological treatment of bipolar disorder among children and adolescents. Expert Rev Neurother (2007) 0.79

Treatments in child and adolescent bipolar disorders. Eur Child Adolesc Psychiatry (2006) 0.79

Treatment development and feasibility study of family-focused treatment for adolescents with bipolar disorder and comorbid substance use disorders. J Psychiatr Pract (2014) 0.78

Pharmacological treatment of adolescent pathological gambling. Int J Adolesc Med Health (2010) 0.77

Lithium in bipolar adolescents with secondary substance dependency. J Am Acad Child Adolesc Psychiatry (1999) 0.75

Pharmacotherapy for Substance Use Disorders in Youths. J Child Adolesc Subst Abuse (2016) 0.75

Evaluation of guideline-concordant care for bipolar disorder among privately insured youth. Prim Care Companion J Clin Psychiatry (2010) 0.75

Parental Warmth and Risks of Substance Use in Children with Attention-Deficit/Hyperactivity Disorder: Findings from a 10-12 Year Longitudinal Investigation. Addict Res Theory (2014) 0.75

The Impact of Motivational Interviewing on Delinquent Behaviors in Incarcerated Adolescents. J Subst Abuse Treat (2015) 0.75

Child and adolescent bipolar disorder. Paediatr Child Health (2001) 0.75

Treatment of Pediatric Bipolar Disorder: A Review. Minerva Psichiatr (2011) 0.75

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism. Neuropsychiatr Dis Treat (2010) 0.75

Psychosis in children: diagnosis and treatment. Dialogues Clin Neurosci (2001) 0.75

Lithium is Clearly Underutilized in Child Psychiatry. Chin Med J (Engl) (2016) 0.75

Medication use in adolescents treated in a French psychiatric setting for acute manic or mixed episode. J Can Acad Child Adolesc Psychiatry (2009) 0.75

A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use. Psychopharmacology (Berl) (2017) 0.75

Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder. CNS Drugs (2017) 0.75

Articles by these authors

The sequence of the human genome. Science (2001) 101.55

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24

Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32

A Critical Study of the Methods of Estimating Cholesterol and Allied Substances. Biochem J (1921) 4.58

A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol (1988) 4.41

Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J (2001) 4.40

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA (2001) 4.34

Lymphocyte trafficking and regional immunity. Adv Immunol (1999) 4.21

[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther (1989) 4.18

Distribution of NHS funds between fundholding and non-fundholding practices. BMJ (1994) 4.05

Enrichment of gene-coding sequences in maize by genome filtration. Science (2003) 3.41

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis (2000) 3.37

Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol (1993) 3.36

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A (2000) 3.34

Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet (1985) 3.32

Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health. BMJ (1996) 3.18

AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation (2000) 3.05

Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate. Science (1977) 2.88

Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry (2001) 2.83

Final results from a meta-analysis of remedial interventions with drink/drive offenders. Addiction (1995) 2.66

Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer (1998) 2.36

Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem (2000) 2.20

Incentive spirometry decreases respiratory complications following major abdominal surgery. Surgeon (2007) 2.15

Possible discrimination in recruitment of psychiatry residents? Am J Psychiatry (1997) 2.14

Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA (1988) 2.12

The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest (1990) 2.12

Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF. J Affect Disord (1998) 2.10

Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci (1997) 2.09

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial. Biol Psychiatry (1996) 2.07

Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res (2001) 2.05

British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05

Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) Hum Mol Genet (1995) 2.02

The segment polarity gene armadillo interacts with the wingless signaling pathway in both embryonic and adult pattern formation. Development (1991) 2.01

Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem (1992) 2.01

Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99

CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther (1989) 1.99

Purine receptors in mammalian tissues: pharmacology and functional significance. Annu Rev Pharmacol Toxicol (1987) 1.97

Histopathology of the upper small intestines in typhoid fever. Biopsy study of experimental disease in man. Am J Dig Dis (1966) 1.97

Helix formation between polyribonucleotides and purines, purine nucleosides and nucleotides. II. J Mol Biol (1966) 1.93

Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J (1999) 1.90

Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol (1992) 1.87

Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science (1998) 1.87

P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther (2000) 1.85

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry (1998) 1.85

Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet (1998) 1.83

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry (1989) 1.79

Activation of expression of hedgehog target genes in basal cell carcinomas. J Invest Dermatol (2001) 1.77

Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation (2001) 1.74

Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J Am Acad Child Adolesc Psychiatry (2000) 1.74

Peer discussion on training physicians to be competent communicators: support for a multiple discourse approach. South Med J (1997) 1.73

Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry (1996) 1.72

Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother (1998) 1.72

Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst (1994) 1.72

A phosphatocopid crustacean with appendages from the Lower Cambrian. Science (2001) 1.70

Adherence by African American men to prostate cancer education and early detection. Cancer (1999) 1.69

Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry (1997) 1.68

Liver cells. Methods Enzymol (1979) 1.67

The carbon balance of Africa: synthesis of recent research studies. Philos Trans A Math Phys Eng Sci (2011) 1.65

Circadian time of morning light administration and therapeutic response in winter depression. Arch Gen Psychiatry (2001) 1.64

Sensitivity of Shah, Vanclay and Cooper's modified Barthel Index. Clin Rehabil (1999) 1.62

Gene rearrangements in the diagnosis of lymphoma/leukemia. Guidelines for use based on a multiinstitutional study. Am J Clin Pathol (1991) 1.61

Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol (2000) 1.61

The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res (1999) 1.60

Neuronal nicotinic acetylcholine receptors as novel drug targets. J Pharmacol Exp Ther (2000) 1.60

Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med (2012) 1.60

Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry (2001) 1.59

HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse (1998) 1.58

UK Back pain Exercise And Manipulation (UK BEAM) trial--national randomised trial of physical treatments for back pain in primary care: objectives, design and interventions [ISRCTN32683578]. BMC Health Serv Res (2003) 1.57

Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets. Blood (1998) 1.56

One minute wisdom. All you need to know about CS gas. Nurs Stand (1994) 1.55

Assessment of functional capacity in clinical and research applications: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation (2000) 1.55

Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. Diabetes (1990) 1.55

Autonomic orienting responses in 15-year-old male subjects and criminal behavior at age 24. Am J Psychiatry (1990) 1.54

Sale of sex for drugs and drugs for sex: an economic context of sexual risk behavior for STDs. Sex Transm Dis (1999) 1.53

Recent advances in understanding the pathogenesis of Huntington's disease. Trends Neurosci (1999) 1.53

Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg (1997) 1.52

CT appearances of talc pleurodesis. Clin Radiol (2007) 1.52

Nature of the bleeding vessel in recurrently bleeding gastric ulcers. Gastroenterology (1986) 1.50

Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking. Proc Natl Acad Sci U S A (1989) 1.50

Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50

First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50

The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view. Br J Rheumatol (1995) 1.49

Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults. J Hum Hypertens (2012) 1.49

22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am J Med Genet A (2010) 1.49

Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. J Pediatr (1984) 1.48

The hypronosticon test in breast cancer. Clin Oncol (1975) 1.47

Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut (2010) 1.47

A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci U S A (1993) 1.47

Beta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunit. J Cell Biol (1995) 1.46

Gender-related differences in cocaine toxicity in the rat. J Lab Clin Med (1993) 1.46

Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis (2001) 1.44

Improved therapies for Parkinson's disease: life beyond dopamine D2/D3 receptor agonists. Trends Pharmacol Sci (1997) 1.44

Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells. J Clin Endocrinol Metab (1999) 1.44

Plasma haloperidol levels and clinical effects in schizophrenia and schizoaffective disorder. Arch Gen Psychiatry (1995) 1.43

Measles epidemiology and outbreak response immunization in a rural community in Peru. Bull World Health Organ (1999) 1.43

Agonist derived molecular probes for A2 adenosine receptors. J Mol Recognit (1989) 1.43